Hong Leong Asia Ltd.
Hong Leong Asia Ltd. (H22.SI) Financial Performance & Income Statement Overview
Analyze Hong Leong Asia Ltd. (H22.SI) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Hong Leong Asia Ltd. (H22.SI) Income Statement & Financial Overview
Explore comprehensive income reports for Hong Leong Asia Ltd. H22.SI, broken down by year and quarter.
| Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.13B | $1.13B | $1.003B | $1.003B |
| Cost of Revenue | $915.55M | $915.55M | $808.02M | $808.02M |
| Gross Profit | $210.06M | $210.06M | $195.16M | $195.16M |
| Gross Profit Ratio | $0.19 | $0.19 | $0.19 | $0.19 |
| R&D Expenses | $36.68M | $36.68M | $43.88M | $43.88M |
| SG&A Expenses | $136.30M | $136.30M | $134.18M | $134.18M |
| Operating Expenses | $172.98M | $172.98M | $152.07M | $152.07M |
| Total Costs & Expenses | $1.09B | $1.09B | $960.09M | $960.09M |
| Interest Income | $0.00 | $0.00 | $0.00 | $5.62M |
| Interest Expense | $18.002M | $0.00 | $19.25M | $0.00 |
| Depreciation & Amortization | $40.18M | $40.18M | $30.57M | $30.57M |
| EBITDA | $77.08M | $77.08M | $43.11M | $43.11M |
| EBITDA Ratio | $0.07 | $0.07 | $0.04 | $0.04 |
| Operating Income | $37.08M | $37.08M | $12.54M | $12.54M |
| Operating Income Ratio | $0.03 | $0.03 | $0.01 | $0.01 |
| Other Income/Expenses (Net) | $23.11M | $23.11M | $24.93M | $24.93M |
| Income Before Tax | $60.19M | $60.19M | $37.47M | $37.47M |
| Income Before Tax Ratio | $0.05 | $0.05 | $0.04 | $0.04 |
| Income Tax Expense | $14.002M | $14.002M | $9.56M | $9.56M |
| Net Income | $24.77M | $24.77M | $17.05M | $17.05M |
| Net Income Ratio | $0.02 | $0.02 | $0.02 | $0.02 |
| EPS | $0.03 | $0.03 | $0.02 | $0.02 |
| Diluted EPS | $0.03 | $0.03 | $0.02 | $0.02 |
| Weighted Avg Shares Outstanding | $749.55M | $749.55M | $747.98M | $747.98M |
| Weighted Avg Shares Outstanding (Diluted) | $748.00M | $748.00M | $748.003M | $748.003M |
Over the past four quarters, Hong Leong Asia Ltd. demonstrated steady revenue growth, increasing from $1.003B in Q3 2023 to $1.13B in Q2 2024. Operating income reached $37.08M in Q2 2024, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $77.08M, reflecting operational efficiency. Net income rose to $24.77M, with EPS at $0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan